APOBEC3B deletion and risk of HIV-1 acquisition

J Infect Dis. 2009 Oct 1;200(7):1054-8. doi: 10.1086/605644.

Abstract

The human APOBEC3 family of cytidine deaminases provides intrinsic immunity to retroviral infection. A naturally occurring 29.5-kb deletion removes the entire APOBEC3B gene. We examined the impact of the APOBEC3B gene deletion in >4000 individuals from 5 human immunodeficiency virus type 1 (HIV-1) natural history cohorts. The hemizygous genotype had no effect on either acquisition of HIV-1 infection or progression to AIDS. However, the homozygous deletion was significantly associated with unfavorable outcomes for HIV-1 acquisition (odds ratio, 7.37; P= .024), progression to AIDS (relative hazard, 4.01; P=. 03), and viral set point (P= .04). These findings suggest that the loss of APOBEC3B may increase host susceptibility to HIV-1 acquisition and progression to AIDS and warrant further study.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Cytidine Deaminase / genetics*
  • Ethnicity
  • Gene Deletion
  • Gene Expression Regulation / physiology
  • Genetic Predisposition to Disease*
  • HIV Infections / genetics*
  • HIV-1*
  • Heterozygote
  • Homozygote
  • Humans
  • Minor Histocompatibility Antigens

Substances

  • Minor Histocompatibility Antigens
  • APOBEC3B protein, human
  • Cytidine Deaminase